Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer-Reference-Cited by-同舟云学术

Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer

Published:2014-11 Issue:11 Volume:10 Page:3201-3213
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

NoeDominguez-Romero Allan,Zamora-Alvarado Rubén,Servín-Blanco Rodolfo,Pérez-Hernández Erendira G,Castrillon-Rivera Laura E,Munguia Maria Elena,Acero Gonzalo,Govezensky Tzipe,Gevorkian Goar,Manoutcharian Karen

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.29679

Reference39 articles.

1. Tumor vaccines in 2010: Need for integration

2. Adaptive immunity maintains occult cancer in an equilibrium state

3. Cancer immunoediting by the innate immune system in the absence of adaptive immunity

4. Experimental mouse tumour models: what can be learnt about human cancer immunology?

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2;Computers in Biology and Medicine;2023-09

2. Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications;International Journal of Molecular Sciences;2023-07-23

3. Tumor antigen-unbiased variable epitope library contains mimotopes with antitumor effect in a mouse model of breast cancer;Molecular Immunology;2023-05

4. Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study;Vaccines;2023-03-13

5. Genomic instability, origin and evolution of cancer, and personalized immunotherapy;Vacunas (English Edition);2022-09